King Pharmaceuticals KG International — Total IBNR
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's international — total ibnr.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's international — total IBNR?
- King Pharmaceuticals (KG) reported international — total IBNR of 313,500,000% in Q4 2025.
- What does international — total IBNR mean?
- This metric measures the total reserves held for Incurred But Not Reported (IBNR) claims within the international segment. It represents the estimated liability for losses that have occurred but have not yet been formally reported to the insurer. Accurate IBNR estimation is critical for maintaining solvency and ensuring that the company has sufficient capital to meet future obligations.